That is why, some 50 years after NORML first began this fight, I am pleased to see the federal government finally acknowledge what we – and millions of Americans – have known all along: That marijuana is a legitimate therapy for many Americans and that it doesn’t belong in Schedule I.
“I was so happy with the internship that I did it twice! It has been so inspiring and educational to be involved with policy in this way.”
“Most Americans have tried cannabis and few regret having done so. This is reflected in the public’s consistent support for legalizing and regulating cannabis.”
If certified for the ballot, it will be the third time since 2020 that South Dakotans have weighed in on the legalization issue.
“When it comes to retail cannabis, the prevailing attitude is ‘Buy American.'”
Perhaps most tellingly, our political opponents are also touting its significance, pledging to take whatever steps necessary to derail this proposed policy change.
“It is significant for these federal agencies, and the DEA and FDA in particular, to acknowledge publicly for the first time what many patients and advocates have known for decades: that cannabis is a safe and effective therapeutic agent for tens of millions of Americans.”
“These findings, and others, refute hypothesized associations between cannabis use and low motivation. It is unfortunate that many of these longstanding stereotypes have historically guided public health messaging about cannabis and have also been used to stigmatize and discriminate against those who consume it responsibly.”